Skip to main content
Market icon

¿Casos de sarampión en EE. UU. antes del 30 de abril?

Market icon

¿Casos de sarampión en EE. UU. antes del 30 de abril?

Polymarket

$194,597 Vol.

Polymarket

$194,597 Vol.

1800

$51,996 Vol.

64%

1850

$5,501 Vol.

18%

1900

$50,792 Vol.

7%

1,950

$20,403 Vol.

3%

2000

$42,683 Vol.

3%

2100

$7,283 Vol.

2%

2200

$15,939 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of the latest Centers for Disease Control and Prevention (CDC) report on April 9, 2026—updated April 10—1,714 confirmed measles cases have been reported in the United States this year, spanning 17 outbreaks across 33 jurisdictions and linked to 94% of cases, primarily in under-vaccinated communities. Declining MMR vaccine coverage among kindergartners (92.5% in 2024–2025, below the 95% herd immunity threshold) and imported cases from global hotspots fuel transmission, with recent weekly surges like 73 new Utah cases pushing totals near 1,700. Traders should monitor Thursday CDC updates for case trajectories through April 30, as containment efforts and surveillance could curb spread amid high contagiousness (R0 12–18).

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$194,597
Fecha de finalización
30 abr 2026
Mercado abierto
Apr 14, 2026, 9:30 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of the latest Centers for Disease Control and Prevention (CDC) report on April 9, 2026—updated April 10—1,714 confirmed measles cases have been reported in the United States this year, spanning 17 outbreaks across 33 jurisdictions and linked to 94% of cases, primarily in under-vaccinated communities. Declining MMR vaccine coverage among kindergartners (92.5% in 2024–2025, below the 95% herd immunity threshold) and imported cases from global hotspots fuel transmission, with recent weekly surges like 73 new Utah cases pushing totals near 1,700. Traders should monitor Thursday CDC updates for case trajectories through April 30, as containment efforts and surveillance could curb spread amid high contagiousness (R0 12–18).

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$194,597
Fecha de finalización
30 abr 2026
Mercado abierto
Apr 14, 2026, 9:30 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Casos de sarampión en EE. UU. antes del 30 de abril?" es un mercado de predicción en Polymarket con 7 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "1800" con 64%, seguido de "1850" con 18%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 64¢ implica que el mercado colectivamente asigna una probabilidad de 64% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "¿Casos de sarampión en EE. UU. antes del 30 de abril?" ha generado $194.6K en volumen total de trading desde que el mercado se lanzó el Mar 24, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "¿Casos de sarampión en EE. UU. antes del 30 de abril?", explora los 7 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Casos de sarampión en EE. UU. antes del 30 de abril?" es "1800" con 64%, lo que significa que el mercado asigna una probabilidad de 64% a ese resultado. El siguiente resultado más cercano es "1850" con 18%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Casos de sarampión en EE. UU. antes del 30 de abril?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.